Formulation of Risperidone Nano Niosomal Vesicular System by Ecofriendly Direct Ultrasonication Method
DOI:
https://doi.org/10.31351/vol34iss2pp250-258Keywords:
Dicetyl Phosphate, Nanovesicular, Risperidone, Span 60, UltrasonicationAbstract
Risperidone is atypical antipsychotic agent used mainly in treating schizophrenia, it is classified as class II in BCS classification. Nanovesicular system may provide a circumvent to these hurdles. The aim of this study is to develop a physical stable nanovesicular system with improved characteristics by addition of dicetyl phosphate at various concentrations as charge inducing agent.
The preparation method was ecofriendly direct sonication. Span 60, cholesterol and drug at a fixed amounts were added to different concentrations of dicetyl phosphate ((0,3,6,12,18, and 24mg)/10 mL) to give six formulations, the final mixtures were added to phosphate buffer saline pH 7.4 and sonicated at 60°C without usage of organic solvents along the process of formulation.
Dynamic light scattering, zeta potential, entrapment efficiency percentage, transmission electron microscopy (TEM), and in vitro release were used to assess the characteristics of the formulations. Fourier transform infrared (FTIR) spectra was implemented to investigate possibility of drug-excipients interactions.
The particle size range was (193.97±1.85 - 427.23±199.27nm), particle size distribution (PDI) (0.13±0.06 - 0.62±0.10), TEM showed a vesicular shape of the prepared formula, and entrapment efficiency percentage (48.07±0.20 - 87.40±0.33%).
Formula containing dicetyl phosphate at concentration (18mg/10ml) showed the lowest mean particle size (193.97nm), lowest mean of PDI (0.13), lowest zeta potential mean (-20.10mV), and entrapment efficiency percentage mean of (50.9%). Furthermore, the release was 68.17% of drug after 12 hours, and the FTIR spectra reveals no interaction between drug and excipients in the formula. Most characteristics of risperidone nanovesicles was improved by adding dicetyl phosphate, compared with formulation without dicetyl phosphate.
The main conclusion was that a stable nanovesicular system can be achieved by utilizing direct ultrasonication method and addition of charge inducing agent (dicetyl phosphate) without the need of using organic solvent.
How to Cite
Publication Dates
Received
Revised
Accepted
Published Online First
References
Thabet Y, Elsabahy M, Eissa NG. Methods for preparation of niosomes: A focus on thin-film hydration method. Methods. 2022 Mar 1;199:9–15.
Kaur D, Kumar S. Niosomes: present scenario and future aspects. J Drug Deliv Ther. 2018;8(5):35–43.
Mandal S, Banerjee C, Ghosh S, Kuchlyan J, Sarkar N. Modulation of the photophysical properties of curcumin in nonionic surfactant (Tween-20) forming micelles and niosomes: A comparative study of different microenvironments. J Phys Chem B. 2013 Jun 13;117(23):6957–68. doi:10.1021/jp403724g
Heba A Abou-Taleb RAK, Abdel-Aleem JA. Intranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluation. Drug Des Devel Ther. 2018;12:3501–16. doi:10.2147/DDDT.S177746
Baillie Aj, Florence At, Hume Lr, Muirhead Gt, Rogerson A. The preparation and properties of niosomes—non-ionic surfactant vesicles. J Pharm Pharmacol. 1985 Dec 1;37(12):863–8.
Carafa M, Santucci E, Alhaique F, Coviello T, Murtas E, Riccieri FM, et al. Preparation and properties of new unilamellar non-ionic/ionic surfactant vesicles. Int J Pharm. 1998 Jan 12;160:51–9.
Jabar HE, Abd-Alhammid SN. Improvement of the Solubility and Dissolution Characteristics of Risperidone via Nanosuspension Formulations. Iraqi J Pharm Sci. 2022 Jun 9 ;31(1):43–56.
Correll CU, Kim E, Sliwa JK, Hamm W, Gopal S, Mathews M, et al. Pharmacokinetic characteristics of long-acting injectable antipsychotics for schizophrenia: an overview. CNS Drugs. 2021 Jan 1; 35(1):39–59. doi:10.1007/s40263-020-00779-5
Froelich A, Osmałek T, Jadach B, Puri V, Michniak-Kohn B. Microemulsion-based media in nose-to-brain drug delivery. Pharmaceutics. 2021;13(2):1–37.
Stewart SA, Domínguez-Robles J, McIlorum VJ, Mancuso E, Lamprou DA, Donnelly RF, et al. Development of a biodegradable subcutaneous implant for prolonged drug delivery using 3D printing. Pharmaceutics. 2020 Feb 1;12(2).
Fatma Elzahraa A, Ibrahim E, Mary Kamal G, Ahmed Hassen E, Magdi Ibrahim M. Response surface optimization, Ex vivo and In vivo investigation of nasal spanlastics for bioavailability enhancement and brain targeting of risperidone. Int J Pharm. 2017 Sep 15; 530:1–11.
Abdallah MH, El-Horany HES, El-Nahas HM, Ibrahim TM. Tailoring risperidone-loaded glycethosomal in situ gels using box–behnken design for treatment of schizophrenia-induced rats via intranasal route. Pharmaceutics. 2023 Nov 1;15(11):2521.
Đorđević SM, Santrač A, Cekić ND, Marković BD, Divović B, Ilić TM, et al. Parenteral nanoemulsions of risperidone for enhanced brain delivery in acute psychosis: Physicochemical and in vivo performances. Int J Pharm. 2017 Nov 30;533(2):421–30.
Imam SS, Aqil M, Akhtar M, Sultana Y, Ali A. Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study. Drug Deliv. 2015;22(8):1059–70.
Tchobaniouk L V., McAllister EE, Bishop DL, Carpentier RM, Heins KR, Haight RJ, et al. Once-monthly subcutaneously administered risperidone in the treatment of schizophrenia: Patient considerations. Patient Prefer. Adherence. 2019;13:2233–41.
Mavaddati MA, Moztarzadeh F, Baghbani F. Effect of formulation and processing variables on dexamethasone entrapment and release of niosomes. J Clust Sci. 2015 Nov 1;26(6):2065–78.
Khan MM, Madni A, Tahir N, Parveen F, Khan S, Jan N, et al. Co-delivery of curcumin and cisplatin to enhance cytotoxicity of cisplatin using lipid-chitosan hybrid nanoparticles. Int J Nanomedicine. 2020;15:2207–17.
Khan MI, Madni A, Hirvonen J, Peltonen L. Ultrasonic processing technique as a green preparation approach for diacerein-loaded niosomes. AAPS PharmSciTech. 2017 Jul 1;18(5):1554–63.
Scurti E, Martins JP, Celia C, Palumbo P, Lombardi F, Iannotta D, et al. In vitro characterization and real-time label-free assessment of the interaction of chitosan-coated niosomes with intestinal cellular monolayers. Langmuir. 2023 Jun 13; 39(23):8255–66. doi:10.1021/acs.langmuir.3c00728
Hussein J K, Khalid Kadhem AK. Formulation and evaluation of idebenone microemulsion as a potential approach for the transmucosal drug delivery systems. Iraqi J Pharm Sci.2024 Mar 26;33(1):79–88.
Sambhakar S, Paliwal SK, Sharma S, Sati B, Singh B. Formulation and development of risperidone loaded niosomes for improved bioavailability: In vitro and in vivo study. Acta Pol Pharm - Drug Res. 2017;74(6):1859–73.
Younus Alkwak RS, Rajab NA. Lornoxicam-loaded cubosomes: - preparation and in vitro characterization. Iraqi J Pharm Sci. 2022 Jun 17; 31(1):144–53.
Zhou X, Chen Z. Preparation and performance evaluation of emulsomes as a drug delivery system for silybin. Arch Pharm Res. 2015 Dec 1;38(12):2193–200.
Dong W, Ye J, Wang W, Yang Y, Wang H, Sun T, et al. Self-assembled lecithin/chitosan nanoparticles based on phospholipid complex: A feasible strategy to improve entrapment efficiency and transdermal delivery of poorly lipophilic drug. Int J Nanomedicine. 2020;15:5629–43.
Jacobus Berlitz S, Reginatto P, Machado G da RM, Fuentefria AM, Morisso FDP, Contri RV, et al. Development of a clioquinol nanocarrier as a new, promising option for the treatment of dermatomycosis. Pharmaceutics. 2023;15(2):1–14.
Dubey V, Saini TR. Formulation development and pharmacokinetic studies of long acting in situ depot injection of risperidone. Brazilian J Pharm Sci. 2022 Feb 28;58:e18809.
Salem, HEBA F and Kharshoum RM. Nanoprecipitation technique for preparation of sterically stabilized risperidone nanosuspension: in vitro and in vivo study. Int J Pharm Pharm Sci. 2016;8(5):136-142.
Ayash N, Jassim Z, Hameed A. Preparation and characterization of lacidipine as an oral fast dissolving film. Drug Invent Today. 2018;10:321–6.
Fareed NY, Kassab HJ. Diacerein loaded novasome for transdermal delivery: prepartion , in-vitro characterization and factors affecting formulation. Iraqi J Pharm Sci. 2023 Nov 3 ;32(Suppl.):214–24.
Mostafa MM, Amin MM, Zakaria MY, Hussein MA, Shamaa MM, Abd El-Halim SM. Chitosan Surface-Modified PLGA Nanoparticles Loaded with Cranberry Powder Extract as a Potential Oral Delivery Platform for Targeting Colon Cancer Cells. Pharmaceutics . 2023 Feb 1;15(2):606.
Narayan R, Singh M, Ranjan OP, Nayak Y, Garg S, Shavi G V., et al. Development of risperidone liposomes for brain targeting through intranasal route. Life Sci. 2016 Oct 15;163:38–45.
Németh Z, Csóka I, Semnani Jazani R, Sipos B, Haspel H, Kozma G, et al. Quality by design-driven zeta potential optimisation study of liposomes with charge imparting membrane additives. Pharmaceutics. 2022;14(9).
Noor AD, Rajab NA. Formulation and characterization of niosomes for controlled delivery of tolmetin. J Pharm Negat Results. 2022 Oct 7;13(4):159–69.
Naji GH, Al Gawhari FJ. Study the effect of formulation variables on preparation of nisoldipine loaded nano bilosomes. Iraqi J Pharm Sci. 2023 Nov 4;32(Suppl.):271–82.
Mohanty D, Gilani SJ, Zafar A, Imam SS, Kumar LA, Ahmed MM, et al. Formulation and optimization of alogliptin-loaded polymeric nanoparticles: in vitro to in vivo assessment. Mol. 2022 Jul 13;27(14):4470.
Sankhyan A, Pawar PK. Metformin loaded non-ionic surfactant vesicles: Optimization of formulation, effect of process variables and characterization. DARU, J Pharm Sci. 2013 Jan 11;21(1):1–8.
Sabry S, El hakim Ramadan A, Abd elghany M, Okda T, Hasan A. Formulation, characterization, and evaluation of the anti-tumor activity of nanosized galangin loaded niosomes on chemically induced hepatocellular carcinoma in rats. J Drug Deliv Sci Technol. 2021 Feb 1;61:102163
Hegazy ESA, Sabry GM, Ezz MK, Kamal H, Lotfy S, Mansour SZ, et al. Radiation Synthesis and Characterization of Cholesterol Molecularly Imprinted Polymer of Crosslinked Hydroxyethyl Methacrylate. Int. J. Sci. Res. 2016. 5:297–302.
Rukmangathen R, Yallamalli IM, Yalavarthi PR. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery. Drug Dev Ind Pharm. 2019;45(8):1342–50. doi:10.1080/03639045.2019.1619759
Seju U, Kumar A, Sawant KK. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: In vitro and in vivo studies. Acta Biomater. 2011 Dec 1;7(12):4169–76.
Dilawar N, Ur-Rehman T, Shah KU, Fatima H, Alhodaib A. Development and evaluation of PLGA nanoparticle-loaded organogel for the transdermal delivery of risperidone. Gels. 2022 Nov 2; 8(11):709.
Salarvand M, Ramezani V, Salarvand F, Darabi ZA, Akrami M. Improvement of drug delivery properties of risperidone via preparation of fast dissolution tablet containing nanostructured microparticles. Iran J Pharm Res IJPR. 2021 Mar 1;20(2):183.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Iraqi Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
